Hypoattenuation on CT Angiographic Source Images Predicts Risk of Intracerebral Hemorrhage and Outcome after Intra-Arterial Reperfusion Therapy

References

1. ↵
   del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke—PROACT investigators. Prolyse in acute cerebral thromboembolism. Stroke 1998;29:4–11

   Abstract/FREE Full Text
2. ↵
   Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study—a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003–2011

   CrossRefPubMedWeb of Science
3. ↵
   NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109–2118

   Abstract/FREE Full Text
4. ↵
   Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 1997;28:957–960

   Abstract/FREE Full Text
5. Motto C, Ciccone A, Aritzu E, et al. Hemorrhage after an acute ischemic stroke: MAST-I collaborative group. Stroke 1999;30:761–764

   Abstract/FREE Full Text
6. Jaillard A, Cornu C, Durieux A, et al. Hemorrhagic transformation in acute ischemic stroke: the MAST-E study. Stroke 1999;30:1326–1332

   Abstract/FREE Full Text
7. Multicenter Acute Stroke Trial–Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med. 1996;335:145–150

   CrossRefPubMedWeb of Science
8. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–1025

   CrossRefPubMedWeb of Science
9. ↵
   Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European Australasian Acute Stroke Study investigators. Lancet 1998;352:1245–1251

   CrossRefPubMedWeb of Science
10. ↵
    Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001;32:1330–1335

    Abstract/FREE Full Text
11. ↵
    Molina CA, Alvarez-Sabin J, Montaner J, et al. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke. 2002;33:1551–1556

    Abstract/FREE Full Text
12. ↵
    Roberts HC, Dillon WP, Furlan AJ, et al. Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial. Stroke 2002;33:1557–1565

    Abstract/FREE Full Text
13. ↵
    Dubey N, Bakshi R, Wasay M, Dmochowski J. Early computed tomography hypodensity predicts hemorrhage after intravenous tissue plasminogen activator in acute ischemic stroke. J Neuroimaging 2001;11:184–188

    PubMedWeb of Science
14. Tanne D, Kasner SE, Demchuk AM, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 2002;105:1679–1685

    Abstract/FREE Full Text
15. von Kummer R, Allen KL, Holle R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997;205:327–333

    PubMed
16. Molina CA, Montaner J, Abilleira S, et al. Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke 2001;32:1079–1084

    Abstract/FREE Full Text
17. ↵
    Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: A secondary analysis of the European Australasian Acute Stroke Study (ECASS II). Stroke 2001;32:438–441

    Abstract/FREE Full Text
18. ↵
    Knight RA, Barker PB, Fagan SC, Li Y, Jacobs MA, Welch KM. Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. Stroke 1998;29:144–151

    Abstract/FREE Full Text
19. Adami A, Thijs V, Tong DC, Beaulieu C, Moseley ME, Yenari MA. Use of diffusion weighted MRI to predict the occurrence and severity of hemorrhagic transformation in a rabbit model of embolic stroke. Brain Res 2002;944:32–39

    CrossRefPubMed
20. Tong DC, Adami A, Moseley ME, Marks MP. Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke 2000;31:2378–2384

    Abstract/FREE Full Text
21. Tong DC, Adami A, Moseley ME, Marks MP. Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging. Arch Neurol 2001;58:587–593

    CrossRefPubMed
22. ↵
    Selim M, Fink JN, Kumar S, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 2002;33:2047–2052

    Abstract/FREE Full Text
23. ↵
    Hunter GJ, Hamberg LM, Ponzo JA, et al. Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results. AJNR Am J Neuroradiol 1998;19:29–37

    Abstract
24. ↵
    Lev MH, Farkas J, Rodriguez VR, et al. CT angiography in the rapid triage of patients with hyperacute stroke to intraarterial thrombolysis: accuracy in the detection of large vessel thrombus. J Comput Assist Tomogr 2001;25:520–528

    CrossRefPubMed
25. Knauth M, von Kummer R, Jansen O, Hahnel S, Dorfler A, Sartor K. Potential of CT angiography in acute ischemic stroke. AJNR Am J Neuroradiol 1997;18:1001–1010

    Abstract
26. ↵
    Wildermuth S, Knauth M, Brandt T, Winter R, Sartor K, Hacke W. Role of CT angiography in patient selection for thrombolytic therapy in acute hemispheric stroke. Stroke 1998;29:935–938

    Abstract/FREE Full Text
27. Klotz E, Konig M. Perfusion measurements of the brain: using dynamic CT for the quantitative assessment of cerebral ischemia in acute stroke. Eur J Radiol 1999;30:170–184

    PubMed
28. ↵
    Lev MH, Segal AZ, Farkas J, et al. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome. Stroke 2001;32:2021–2028

    Abstract/FREE Full Text
29. Schramm P, Schellinger PD, Fiebach JB, et al. Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 hours after onset. Stroke 2002;33:2426–2432

    Abstract/FREE Full Text
30. ↵
    Berzin TM, Lev MH, Goodman D, et al. CT perfusion imaging versus MR diffusion weighted imaging: prediction of final infarct size in hyperacute stroke. Stroke 2001;32:317
31. ↵
    Budzik R, Pergolizzi R, Putman C. Intraarterial thrombolysis for acute ischemic stroke. Semin Neurosurg 2000;11:107–132
32. ↵
    Greer DA, Koroshetz WJ, Cullen S, Gonzalez RG, and Lev MH. Magnetic resonance imaging improves detection of intracerebral hemorrhage over computed tomography after intra-arterial thrombolysis. Stroke 2004;35:491–495

    Abstract/FREE Full Text
33. ↵
    National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587

    CrossRefPubMedWeb of Science
34. ↵
    Lev MH, Farkas J, Gemmete JJ, et al. Acute stroke: improved nonenhanced CT detection—benefits of soft-copy interpretation by using variable window width and center level settings. Radiology 1999;213:150–155

    PubMedWeb of Science
35. ↵
    Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman and Hall;1993
36. ↵
    Wechsler LR, Roberts R, Furlan AJ, et al, for the PROACT II investigators. Factors influencing outcome and treatment effect in PROACT II. Stroke 2003;34:1224–1229

    Abstract/FREE Full Text
37. ↵
    Gilligan AK, Markus R, Read S, et al. Baseline blood pressure but not early computed tomography changes predicts major hemorrhage after streptokinase in acute ischemic stroke. Stroke 2002;33:2236–2242

    Abstract/FREE Full Text
38. ↵
    Lee KH, Cho SJ, Byun HS, et al. Triphasic perfusion computed tomography in acute middle cerebral artery stroke: a correlation with angiographic findings. Arch Neurol 2000;57:990–999

    CrossRefPubMedWeb of Science
39. ↵
    Bove P, Lev MH, Chaves T, et al. CT perfusion imaging of hyperacute stroke: subtraction analysis of infarct conspicuity. Oak Brook, IL: American Society of Neuroradiology. Proceedings of the 39th Annual Meeting of the American Society of Neuroradiology. 2001 .
40. ↵
    Ezzeddine MA, Lev MH, McDonald CT, et al. CT angiography with whole brain perfused blood volume imaging: added clinical value in the assessment of acute stroke. Stroke 2002;33:959–966

    Abstract/FREE Full Text
41. ↵
    Haaga JR, Alfidi RJ. Computed Tomography of the Whole Body. Washington, DC: C. V. Mosby;1988
42. ↵
    Hayman LA, Evans RA, Bastion FO, Hinck VC. Delayed high dose contrast CT: identifying patients at risk of massive hemorrhagic infarction. AJR Am J Roentgenol 1981;136:1151–1159

    PubMedWeb of Science